What We're Reading
Industry reads hand-picked by our editors
May 10, 2024
May 09, 2024
-
KFF Health News
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
-
Fierce Biotech
Sanofi CSO Frank Nestle is leaving
-
The Wall Street Journal
Neuralink’s First Brain-Chip Implant in a Human Appeared Flawless. There Was a Problem.
May 08, 2024
May 07, 2024
May 06, 2024
-
FirstWord Pharma
Pfizer taps Citi analyst Andrew Baum as strategy chief
-
Fierce Biotech
GlycoMimetics fails phase 3 blood cancer trial, sinking stock
-
Politico
‘They need to back off’: Farm states push back on Biden’s bird flu response
-
The Wall Street Journal
‘Green Shoots’ Grow Out of Control on Wall Street
May 03, 2024
-
Fierce Pharma
WuXi Biologics withdraws from 2024 BIO convention amid worsening geopolitical tensions
-
NPR
Could the U.S. produce an effective bird flu vaccine for humans, if needed?
-
Healthcare Dive
Walgreens inks GLP-1 clinical trial deal with major German drugmaker
-
JAMA
The FDA and Gene Therapy for Duchenne Muscular Dystrophy